Sunday, August 2, 2026

South Korea Vows to Pursue Dialogue Despite North’s Rejection of Engagement

South Korea acknowledges Kim Yo Jong's statement rejecting talks, highlighting deep distrust. The government remains committed to improving relations.

Kia’s First-Quarter Sales Hit Record High, Thanks to SUV and EV Push

Kia's Q1 sales hit a record 772,351 units, driven by strong SUV demand, despite a dip in South Korea.

Google Cloud and Samsung Team Up: What Does Gemini Enterprise Mean for AI in 2026?

Google Cloud partners with Samsung to implement its Gemini Enterprise platform, enhancing AI capabilities for employees in South Korea.

News1

Author's Latest

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Revolutionizing Healthcare: How Low-Risk NK Cell Therapy is Changing Regenerative Medicine in 2026

The Ministry of Health reclassifies autologous immune cell cultivation as low risk, expediting treatment access while ensuring safety.

2026 Nature Conference: Exploring the Future of Autonomous Robotics at KAIST

KAIST will host the first Nature Conference on Autonomous Robotics, showcasing innovations and discussions on the future of robotics.

How Hyundai’s 100 Million USD Investment in Boston Dynamics is Set to Transform Robotics and AI by 2027

Boston Dynamics invests $100M in a new robotics and AI center in Massachusetts to streamline operations and boost job creation by 2033.

Lotte Biologics says it has secured top-10 global CDMO manufacturing capacity [BIO USA]

Lotte Biologics is set to begin commercial production by the end of 2026, advancing its capabilities in the global CDMO market.

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

NVP Healthcare Signs Exclusive Supply Deal for NVP-1702 With Brazil’s Marjan Farma at BIO USA

NVP Healthcare signs a deal with Marjan Farma to supply its probiotic NVP-1702 for liver health products in Brazil, aiming for market expansion.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

LG CNS Launches PerfectWin ERP Edition with AI Automation for Enhanced SAP Testing Efficiency

LG CNS launched the Perfect Win ERP Edition, an AI-driven tool that automates SAP ERP testing, enhancing efficiency and reliability.

How Does the EMU-370 Compare to KTX? A Deep Dive into Korea’s Next-Gen High-Speed Rail

The 2026 National Land Transportation Technology Exhibition in Seoul showcases innovations like high-speed trains, driving simulators, and smart construction tech.

Z.ai’s GLM-5.2 Surpasses Google Gemini: What This Means for AI in Asia

ZhipuAI's GLM-5.2 outperforms Google's Gemini, achieving high scores in AI evaluations and offering competitive pricing for its API.

AhnLab V3 Achieves A+ Certification: The Only Endpoint Security Solution with 100% Malware Detection

AhnLab's V3 security solution achieved A+ certification with a 100% malware detection rate, excelling in accuracy and reliability.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.